Article Text

PDF
Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures
  1. S E Heron1,2,
  2. K Cox1,
  3. B E Grinton3,
  4. S M Zuberi4,
  5. S Kivity5,
  6. Z Afawi6,
  7. R Straussberg5,
  8. S F Berkovic3,
  9. I E Scheffer3,7,
  10. J C Mulley1,2,8
  1. 1
    Department of Genetic Medicine, Women’s and Children’s Hospital, North Adelaide, South Australia, Australia
  2. 2
    School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, South Australia, Australia
  3. 3
    Department of Medicine (Neurology), University of Melbourne and Austin Health, Heidelberg, Victoria, Australia
  4. 4
    Fraser of Allander Neurosciences Unit, Royal Hospital for Sick Children, Yorkhill, Glasgow, UK
  5. 5
    Schneider Children’s Medical Center, Petaq Tikva, Israel
  6. 6
    Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
  7. 7
    Department of Paediatrics, University of Melbourne, Royal Children’s Hospital, Melbourne, Victoria, Australia
  8. 8
    School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia
  1. Ms S Heron, Department of Genetic Medicine, Women’s and Children’s Hospital, 72 King William Road, North Adelaide SA 5006, Australia; sarah.heron{at}cywhs.sa.gov.au

Abstract

Background: Benign familial neonatal seizures are most often caused by mutations in the voltage-gated potassium channel subunit gene KCNQ2. More than 60 mutations have been described in BFNS families, approximately half of which lead to protein truncation. The hypothesis of this study was that deletion or duplication of ⩾1 exons of KCNQ2 could cause BFNS in cases without coding or splicing mutations.

Methods: Multiplex ligation-dependent probe amplification (MLPA) was used to test a group of 21 unrelated patients with clinical features consistent with either BFNS, benign familial neonatal–infantile seizures or sporadic neonatal seizures, for exonic deletions and duplications.

Results: Three deletions and one duplication mutation were identified in four familial cases and cascade testing of their available family members showed that the mutations segregated with the phenotype in each family. The junction fragment for one of the deletions was amplified by PCR and sequenced to characterise the breakpoint and verify that a deletion had occurred.

Conclusions: Submicroscopic deletions or duplications of KCNQ2 are seen in a significant proportion of BFNS families: four of nine (44%) cases previously testing negative for coding or splice site mutation by sequencing KCNQ2 and KCNQ3. MLPA is an efficient second-tier testing strategy for KCNQ2 to identify pathogenic intragenic mutations not detectable by conventional DNA sequencing methods.

  • neonatal seizures
  • deletion
  • duplication
  • epilepsy
  • potassium channel
  • MLPA

Statistics from Altmetric.com

Footnotes

  • Competing interests: none declared.

  • Abbreviations:
    BFNIS
    benign familial neonatal-infantile seizures
    BFNS
    benign familial neonatal seizures
    MLPA
    multiplex ligation-dependent probe amplification
    OMIM
    Online Mendelian Inheritance in Man

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.